These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 7199273

  • 1. Renal complications of cis-diamminedichloroplatinum.
    Nitschke R.
    Ann Clin Lab Sci; 1981; 11(5):392-6. PubMed ID: 7199273
    [Abstract] [Full Text] [Related]

  • 2. [Can cisplatin renal toxicity be prevented?].
    Brillet G, Deray G, Bunker D, Ben Hmida M, Baumelou A, Jacobs C.
    Nephrologie; 1991; 12(3):143-6. PubMed ID: 1922654
    [Abstract] [Full Text] [Related]

  • 3. Protective effect of organic cation transport inhibitors on cis-diamminedichloroplatinum-induced nephrotoxicity.
    Bird JE, Walser MM, Quebbemann AJ.
    J Pharmacol Exp Ther; 1984 Dec; 231(3):752-8. PubMed ID: 6542140
    [Abstract] [Full Text] [Related]

  • 4. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
    Esposito M, Vannozzi M, Viale M, Pellecchia C, Civalleri D, Gogioso L.
    Anticancer Res; 1995 Dec; 15(6B):2541-7. PubMed ID: 8669820
    [Abstract] [Full Text] [Related]

  • 5. Nephrotoxicity of cis-diamminedichloroplatinum(II) as measured by urinary beta-glucuronidase.
    Kuhn JA, Argy WP, Rakowski TA, Moriarty JK, Schreiner GE, Schein PS.
    Cancer Treat Rep; 1980 Dec; 64(10-11):1083-6. PubMed ID: 7193087
    [Abstract] [Full Text] [Related]

  • 6. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
    Konstantinov S, Topashka-Ancheva M, Karaivanova M, Zoneva G, Galova I.
    Neoplasma; 1994 Dec; 41(5):253-8. PubMed ID: 7854494
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD, Weaver RJ, Stewart KN, Brown P, Hawksworth GM.
    Toxicology; 2008 Jul 30; 249(2-3):184-93. PubMed ID: 18583013
    [Abstract] [Full Text] [Related]

  • 13. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
    Launay-Vacher V, Rey JB, Isnard-Bagnis C, Deray G, Daouphars M, European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
    Cancer Chemother Pharmacol; 2008 May 30; 61(6):903-9. PubMed ID: 18317762
    [Abstract] [Full Text] [Related]

  • 14. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
    Lajer H, Kristensen M, Hansen HH, Nielsen S, Frøkiaer J, Ostergaard LF, Christensen S, Daugaard G, Jonassen TE.
    Cancer Chemother Pharmacol; 2005 Nov 30; 56(5):535-42. PubMed ID: 15947931
    [Abstract] [Full Text] [Related]

  • 15. Cisplatin-induced hypocalcemia and hypomagnesemia.
    Lyman NW, Hemalatha C, Viscuso RL, Jacobs MG.
    Arch Intern Med; 1980 Nov 30; 140(11):1513-4. PubMed ID: 7192079
    [Abstract] [Full Text] [Related]

  • 16. Methods of reduction of cisplatin nephrotoxicity.
    Walker EM, Gale GR.
    Ann Clin Lab Sci; 1981 Nov 30; 11(5):397-410. PubMed ID: 6277229
    [Abstract] [Full Text] [Related]

  • 17. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats.
    Ateşşahín A, Ceríbaşi AO, Yuce A, Bulmus O, Cikim G.
    Basic Clin Pharmacol Toxicol; 2007 Feb 30; 100(2):121-6. PubMed ID: 17244261
    [Abstract] [Full Text] [Related]

  • 18. cis-Diamminedichloroplatinum-induced hypomagnesemia and renal magnesium wasting.
    Bell DR, Woods RL, Levi JA.
    Eur J Cancer Clin Oncol; 1985 Mar 30; 21(3):287-90. PubMed ID: 4040020
    [Abstract] [Full Text] [Related]

  • 19. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research.
    Ali BH, Al Moundhri MS.
    Food Chem Toxicol; 2006 Aug 30; 44(8):1173-83. PubMed ID: 16530908
    [Abstract] [Full Text] [Related]

  • 20. Acute nephrotoxicity following cis-dichlorodiammine-platinum.
    Bitran JD, Desser RK, Billings AA, Kozloff MF, Shapiro CM.
    Cancer; 1982 May 01; 49(9):1784-8. PubMed ID: 7200396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.